Close Menu

NEW YORK (GenomeWeb) – Precipio said today that it has inked an agreement to jointly offer its ICE COLD-PCR (ICP) mutation enrichment technology with PerkinElmer's NextPrep-Mag cell-free DNA isolation kit, Janus G3 liquid handling workstation, and Chemagic MSM I, Chemagic 360, and Chemagic Prime platforms.

Precipio and PerkinElmer anticipate providing an automated cell-free DNA analysis workflow alongside mutation enrichment technology in ICE COLD-PCR to enable lab-based liquid biopsy testing.

Financial terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Aug
19
Sponsored by
UgenTec

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.